MedTrace Logo

Initialization of Methadone in Primary Care, Randomized Intervention Research for Preventing HCV Transmission Practices

NCT00657397 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 197

Last updated 2012-07-24

No results posted yet for this study

Summary

The rapid scale up of opioid substitution treatment (OST) for drug users mainly achieved through the possibility of prescribing buprenorphine in primary care has been successful in reducing HIV prevalence among drug users but still inadequate for reducing the spread of HCV. To date, methadone in France can only be initialised in drug centres but GPs can prescribe methadone after stabilisation of dosages.

This study was born as an answer to a request from the French Minister of Health that supports the initialisation of methadone in primary care in order to improve coverage by OST (now 70%) in drug users.

Conditions

  • Hepatitis C
  • Substance Dependence
  • Methadone

Interventions

DRUG

Methadone

Methadone sirup once daily

Sponsors & Collaborators

  • French National Agency for Research on AIDS and Viral Hepatitis

    lead OTHER_GOV

Principal Investigators

  • Alain Morel, MD · CSST Le trait d'union, 154 rue du vieux pont de Sèvres, 92100 Boulogne, France

  • Patrizia Carrieri, PHD · ORS PACA - INSERM-IRD UMR912, 23, rue Stanislas Torrents, 13006 Marseille

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00657397 on ClinicalTrials.gov